A cost-effective treatment model in dystrophic epidermolysis bullosa with congenital absence of skin

Kara, Mustafa; Tekgündüz, Kadir Şerafettin; Keskin, Halil

doi:10.1111/dth.12649

Cited by 2 publications

(2 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We reviewed the full text and references of 47 articles, and included 8 additional articles, for a total of 55 articles included in this review (Figure 1). 3,4,6‐58 Most were single or small case series of up to 6 patients, with an additional article by Chiaverini et al 39 reporting on 21 patients in whom gene testing was performed.…”

Section: Resultsmentioning

confidence: 99%

Epidermolysis bullosa with congenital absence of skin: Review of the literature

Martínez‐Moreno¹,

Ocampo‐Candiani²,

Alba‐Rojas³

2020

Pediatric Dermatology

View full text Add to dashboard Cite

In 1966, Bart et al 1 described 20 members of a family with CAS affecting the lower extremities, blistering of the skin and mucous membranes, and nail abnormalities. This association of EB and CAS came to be known as Bart's syndrome (BS). At the time of the first report, the subtypes of EB were not classified because ultrastructural and immunochemical studies were not available. Years later, Zelickson et al 2 performed ultrastructural studies on the initial cases, demonstrating findings of dominant dystrophic epidermolysis

show abstract

Section: Resultsmentioning

confidence: 99%

Epidermolysis bullosa with congenital absence of skin: Review of the literature

Martínez‐Moreno¹,

Ocampo‐Candiani²,

Alba‐Rojas³

2020

Pediatric Dermatology

View full text Add to dashboard Cite

show abstract

“…We used Urgotul which is a no‐adherent petrolatum and hydrocolloid gauze that was available in our hospital at the moment. Due to high cost of these type dressings that combine various components, some authors recommend applied each 2 days (Kara M, 2018) 11 . In addition, we think that exclusively vaselinated gauzes which are cheaper can be used too.…”

Section: Discussionmentioning

confidence: 99%

Type V aplasia cutis congenita in a preterm newborn successfully resolved

Díaz

Menchón

Corrales

et al. 2020

Dermatologic Therapy

View full text Add to dashboard Cite

Aplasia cutis congenita (ACC) associated with fetus papyraceus is a rare subtype of aplasia cutis categorized as type V in Frieden's classification. It is characterized by stellate lesions in a symmetrical distribution over the trunk and proximal extremities. Conservative treatment is recommended, but there is not a well-defined therapeutic protocol. We report the case of a type V ACC in a preterm male newborn with lesions on the trunk and scalp successfully treated with topical 1% silver sulfadiazine and petrolatum gauze with an excellent evolution. This case associates a severe affectation of the scalp which represents a rare variant of type V ACC. K E Y W O R D S aplasia cutis congenita, treatment ACC, type V ACC 1 | INTRODUCTION Aplasia cutis congenita (ACC) is a rare disorder characterized by congenital absence of all skin layers in a localized or extensive area. 1 ACC is most frequently found as a solitary lesion on the scalp. However, face, trunk, buttocks and extremities might be affected. 1 It may present as an isolated defect, accompanied by other developmental abnormalities or within a syndrome. 2 Frieden classified ACC into nine groups based on the distribution of the affected area, associated anomalies, and mode of inheritance. 3

show abstract

A cost-effective treatment model in dystrophic epidermolysis bullosa with congenital absence of skin

Cited by 2 publications

References 7 publications

Epidermolysis bullosa with congenital absence of skin: Review of the literature

Epidermolysis bullosa with congenital absence of skin: Review of the literature

Type V aplasia cutis congenita in a preterm newborn successfully resolved

Contact Info

Product

Resources

About